The rise and fall of a revolutionary drug

Home › The rise and fall of a revolutionary drug

Approved in May 2011, Vertex Pharmaceuticals' hepatitis C drug Incivek hit $457 million in sales in its second full quarter on the market.

27.06	ASTRA 1P satellite successfully launched
27.06	Multiplay service revenue in Singapore to grow at 3.9% CAGR
27.06	ABP Network delivers FAST channels with Amagi
27.06	Private car parks to have 10-minute 'grace period'
27.06	India seeks report on iPhone factory hiring practices
27.06	Would new licences save the North Sea oil and gas industry?
27.06	Atlantic Tropical Weather Outlook
27.06	Eastern North Pacific Tropical Weather Outlook
More »

je.st